Skip to main content
OpenTrials

Clinical trial condition

Pulmonary Disease, Chronic Obstructive

Explore clinical trials studying Pulmonary Disease, Chronic Obstructive. Study availability and eligibility vary by location and protocol.

787 public trials 11 recruiting studies
Refine in advanced search Browse all conditions

Pulmonary Disease, Chronic Obstructive trial results

Completed

A 12-week Study to Evaluate the Efficacy and Safety of Umeclidinium Compared With Tiotropium in Subjects With Chronic Obstructive Pulmonary Disease

NCT02207829

Conditions
Chronic Disease, Disease Attributes, Lung Diseases, +5 more
Locations
  • GSK Investigational Site Spartanburg, South Carolina, United States
  • GSK Investigational Site Buenos Aires, Argentina
  • GSK Investigational Site Buenos Aires, Argentina
  • GSK Investigational Site Winnipeg, Manitoba, Canada
View all 99 locations
View Trial Details
Completed

Efficacy and Safety Study of Fluticasone Furoate (FF)/GW642444 Inhalation Powder and the Individual Components in Subjects With Chronic Obstructive Pulmonary Disease (COPD)

NCT01054885

Conditions
Chronic Disease, Disease Attributes, Lung Diseases, +5 more
Locations
  • GSK Investigational Site Birmingham, Alabama, United States
  • GSK Investigational Site Jasper, Alabama, United States
  • GSK Investigational Site Lakewood, California, United States
  • GSK Investigational Site Long Beach, California, United States
View all 149 locations
View Trial Details
Completed

The Purpose of This Study is to Evaluate the Spirometric Effect (Trough FEV1) of Umeclidinium/Vilanterol 62.5/25 mcg Once Daily Compared With Tiotriopium 18 mcg Once Daily Over a 24-week Treatment Period in Subjects With COPD

NCT01777334

Conditions
Chronic Disease, Disease Attributes, Lung Diseases, +5 more
Locations
  • GSK Investigational Site Tucson, Arizona, United States
  • GSK Investigational Site Riverside, California, United States
  • GSK Investigational Site San Diego, California, United States
  • GSK Investigational Site DeLand, Florida, United States
View all 70 locations
View Trial Details
Completed

Dose Finding Study in COPD

NCT00122434

Conditions
Chronic Disease, Disease Attributes, Lung Diseases, +5 more
Locations
  • UAB Lung Health Center Birmingham, Alabama, United States
  • Vapahcs 111P Palo Alto, California, United States
  • Boehringer Ingelheim Investigational Site San Diego, California, United States
  • GLAHS Sepulveda Sepulveda, California, United States
View all 43 locations
View Trial Details

Related conditions